Full Text View
Tabular View
No Study Results Posted
Related Studies
Stem Cell Transplant for Hematologic Diseases and Renal Cell Cancer (HIMSUM)
This study is currently recruiting participants.
Study NCT00058825   Information provided by Baylor College of Medicine
First Received: April 11, 2003   Last Updated: July 29, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hematologic Malignancies
Additional conditions recognized in this trial
Hematologic Diseases
Hematologic Neoplasms
More general conditions related to this trial
Neoplasms
Neoplasms by Site
Interventions listed in this trial
Campath 1H
Fludarabine
Stem Cell Transplant
TBI
Additional drug interventions recognized in this trial
Alemtuzumab
Fludarabine monophosphate
More general drug interventions related to this trial
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Baylor College of Medicine


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services